Microsoft and AstraZeneca announced that they are joining forces for the launch of AI Factory for Health, a European accelerator for digital health startups focused on artificial intelligence. The three-month accelerator is designed to continue their development in artificial intelligence, cloud computing to push the boundaries of science.
AI Factory for Health Background
Created by Microsoft in collaboration with Inria laboratory, AI Factory is a co-innovation laboratory that connects startups, the world of research and the various players in the sector. Through these synergies, AI Factory for Health projects will serve the patients and the
medical profession to offer a renewed and personalized medicine.
The startups selected to join the AI Factory for Health will do so benefit from AstraZeneca’s know-how and skills in pathologies, knowledge of access to the needs of patients and healthcare professionals, as well as legal competence to institutions and health data for the different European countries in which AstraZeneca operates.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
From tutoring to technical advice on their solutions, to recommendations for promotion and marketing as part of a co-marketing or co-selling approach. Microsoft provides each start-up with personalized support at every stage of its growth. In addition, Microsoft will offer its technological expertise and services from the Azure platform, as well as personalized support, particularly through its commercial network.
The biggest picture
Many practices in health and in the development of therapeutic solutions are, at the moment, transformed by digital technology, making it possible to position the patient at the center of this device, and therefore propose a truly individualized medicine. Artificial intelligence (AI), machine learning, big data and automation improve the patient’s journey from prevention to treatment, diagnosis and quality of life. Thanks to a more precise and regular follow-up of the effects of the drugs or digital companions that will probably answer the questions that have not been asked to the medical team, the patients turn to their care more serenely, in the hospital as at home.
“At AstraZeneca, putting patients first is the fundamental value that guides us in everything we do. We believe that by deepening our understanding of diseases, patient expectations and experiences, we can further improve their quality of life. We also believe that putting patients at the heart of the health care system is a collective effort that draws on the expertise and skills of new partners. That’s why I’m really excited that the AstraZeneca and Microsoft teams are joining forces and laying the foundation stone for their collaboration with AI Factory for Health, ” says Iskra Reic, EVP Europe & Canada, AstraZeneca.
Presentation and start-up criteria
The open application period is now open until October 31stst.
Startups that want to join the program must:
Offer an innovative health solution based on artificial intelligence technology for patients or health professionals
– First fundraising: Seed or Series A, or equivalent development phase. Up to $ 3 million in funding. (Funding information must be verified.)
– Mature project: The startup must engage in the development of a software-based product or service that will be a central element of the current or planned activity.
– Already on the market: The start-up must be engaged in a distribution with at least one customer
– Promising team: Common values and vision
Date: September 11, 2019
Source: Archy news nety